StockData
Camp4 Therapeutics Corp logo

Camp4 Therapeutics Corp (CAMP) stock

CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.00+0.14 (+3.63%)

Close on Nov 17, 2026Market cap $251.01MP/E –Yield 0.00%

Camp4 Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Camp4 Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$28.59M. For fiscal 2025 it was -$29.55M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$29.55M–
FY2024Dec 31, 2024-$45.56M–
FY2023Dec 31, 2023-$44.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.69M–
Q1 FY2026Mar 31, 2026-$10.98M–
Q4 FY2025Dec 31, 2025$6.29M–
Q3 FY2025Sep 30, 2025-$11.22M–
Q2 FY2025Jun 30, 2025-$10.34M–
Q1 FY2025Mar 31, 2025-$14.29M–
Q4 FY2024Dec 31, 2024-$11.29M–
Q3 FY2024Sep 30, 2024-$9.69M–
Q2 FY2024Jun 30, 2024-$13.44M–
Q1 FY2024Mar 31, 2024-$11.14M–
Q4 FY2023Dec 31, 2023-$11.78M–

More Camp4 Therapeutics figures

See a number that looks wrong?